» Articles » PMID: 39719967

Generalized Epileptic Seizures in Fibrodysplasia Ossificans Progressiva Harboring a Recurrent Heterozygous Variant of the Gene (R206H)

Overview
Journal Case Rep Genet
Publisher Wiley
Date 2024 Dec 25
PMID 39719967
Authors
Affiliations
Soon will be listed here.
Abstract

Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare disorder caused by heterozygous pathogenic variants and is characterized by both progressive heterotopic ossification of the soft tissues and congenital malformations of the great toe. In addition to pathological skeletal metamorphosis, patients with FOP experience diverse neurological symptoms such as chronic pain and involuntary movements; however, little is known about the association between FOP and epileptic seizures. We report the case of a young boy with FOP who sustained multiple major fractures due to epileptic loss of consciousness. Based on generalized electroencephalographic abnormalities and the presence of myoclonic movements, the patient was diagnosed with juvenile myoclonic epilepsy. The absence of seizures was well-controlled with valproic acid, whereas occasional abrupt myoclonic movements of the hands and feet persisted. This case expands our understanding of the phenotypic diversity of FOP and the functional versatility of -mediated bone morphogenetic protein (BMP) signaling.

References
1.
Erturk Cetin O, Dogan I, Zanapalioglu U, Yadi F, Tezer D, Demir S . Seizures in inflammatory demyelinating disorders of the central nervous system. Mult Scler Relat Disord. 2024; 85:105535. DOI: 10.1016/j.msard.2024.105535. View

2.
Kitterman J, Strober J, Kan L, Rocke D, Cali A, Peeper J . Neurological symptoms in individuals with fibrodysplasia ossificans progressiva. J Neurol. 2012; 259(12):2636-43. PMC: 3523705. DOI: 10.1007/s00415-012-6562-y. View

3.
Meng X, Wang H, Hao J . Recent progress in drug development for fibrodysplasia ossificans progressiva. Mol Cell Biochem. 2022; 477(10):2327-2334. PMC: 9499916. DOI: 10.1007/s11010-022-04446-9. View

4.
Severino M, Bertamino M, Tortora D, Morana G, Uccella S, Bocciardi R . Novel asymptomatic CNS findings in patients with ACVR1/ALK2 mutations causing fibrodysplasia ossificans progressiva. J Med Genet. 2016; 53(12):859-864. DOI: 10.1136/jmedgenet-2016-104076. View

5.
van Dinther M, Visser N, de Gorter D, Doorn J, Goumans M, de Boer J . ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation. J Bone Miner Res. 2009; 25(6):1208-15. DOI: 10.1359/jbmr.091110. View